How to Reconstitute Semaglutide for In Vitro Research: Complete Lab Guide
The content, articles and product information provided on this website are strictly educational and informational. They are intended to be used for in vitro research only. “In vitro” is a Latin phrase, “in glass,” that refers to research that is conducted outside of a living organism. Note, these products are not pharmaceuticals or medicines and have not been approved by the FDA for the diagnosis, treatment or prevention of any illnesses or disorders. These products are legally prohibited from human or animal consumption.
How to Reconstitute Semaglutide for In Vitro Research: Complete Lab Guide
Semaglutide (MW 4113.6 g/mol, C187H291N45O59) is a GLP-1 receptor agonist incorporating two key structural modifications: an Aib8 substitution for DPP-IV resistance and a C18 fatty diacid chain at Lys26 for albumin binding. It is supplied as a lyophilised powder in a 10mL sterile glass vial containing 5mg of peptide. Due to its fatty acid modification and albumin-binding properties, semaglutide requires slightly more careful handling during reconstitution than unmodified peptides to ensure accurate working concentrations in GLP-1R cell model research applications.
Materials Required
- Semaglutide 5mg lyophilised vial
- Bacteriostatic water (BAC water) — 10mL vial
- 1mL sterile syringe with needle
- Alcohol swabs (70% isopropyl)
- Nitrile gloves
- Permanent marker for labelling
- Refrigerator set to 2–8°C for storage
Pre-Reconstitution Preparation
Inspect the semaglutide vial before use — the lyophilised powder should appear as a white to off-white powder or cake with an intact vial seal. Remove from cold storage and allow to equilibrate to room temperature for 15 minutes before reconstitution. This step is particularly important for semaglutide, as the C18 fatty diacid modification can make the peptide slightly more viscous during dissolution, and starting at room temperature facilitates more even and complete dissolution.
Step-by-Step Reconstitution Protocol
Step 1 — Prepare workspace. Clean the work surface with 70% isopropyl alcohol and allow to dry completely. Wear nitrile gloves throughout the procedure to maintain aseptic conditions.
Step 2 — Swab both stoppers. Wipe the rubber stopper of both the semaglutide vial and the BAC water vial with separate fresh alcohol swabs. Allow to air dry for 10–15 seconds before inserting any needle.
Step 3 — Draw 2mL of BAC water. Using a sterile syringe, draw 2mL of bacteriostatic water. BAC water's benzyl alcohol preservative is essential for multi-use vial compatibility and extends reconstituted stability under refrigeration.
Step 4 — Inject slowly along the vial wall. Angle the needle tip against the inner glass wall of the semaglutide vial and inject the BAC water in a slow, thin stream down the glass over 15–20 seconds. Avoiding direct contact with the powder cake is especially important for semaglutide — its fatty acid side chain makes it more prone to foaming if the solvent stream disrupts the powder directly.
Step 5 — Dissolve by gentle rolling and swirling. Gently roll the vial between your palms and swirl slowly for 60–90 seconds. Semaglutide may take slightly longer to dissolve fully than smaller unmodified peptides due to its molecular weight and lipophilic modification. The solution is fully dissolved when it appears clear and colourless to very slightly opalescent. Do not shake or vortex — foaming can reduce peptide recovery from the vial.
Step 6 — Inspect for clarity. Hold the vial to light and confirm the solution is clear with no visible particles. Any persistent cloudiness may indicate incomplete dissolution — continue gentle swirling for a further 30 seconds before re-inspecting.
Step 7 — Label and record. Mark the vial with reconstitution date, concentration, and researcher initials. Note the 28-day refrigerated stability window on the label.
Resulting Concentration
Adding 2mL BAC water to a 5mg semaglutide vial yields a stock concentration of 2.5mg/mL (2500mcg/mL). For GLP-1R cell model assay applications — cAMP accumulation, receptor binding, or downstream signalling studies — further dilute into cell culture media or assay buffer to achieve working concentrations typically in the 1nM to 1µM range.
Concentration Reference Table
| BAC Water Volume Added | Resulting Concentration |
|---|---|
| 1mL | 5.0mg/mL |
| 2mL | 2.5mg/mL |
| 5mL | 1.0mg/mL |
Storage Conditions and Stability
Store lyophilised semaglutide at −20°C prior to reconstitution, protected from light. Once reconstituted, store at 2–8°C in the refrigerator. Reconstituted semaglutide in BAC water is stable for up to 28 days under refrigeration. Do not freeze reconstituted solution. For long-term aliquot storage, freeze single-use aliquots at −80°C and avoid repeated freeze-thaw cycles which can disrupt the fatty acid-albumin binding conformation.
Research Application Notes
An important consideration specific to semaglutide is its albumin-binding property in serum-containing media. When diluting into standard cell culture media supplemented with FBS or BSA, a significant fraction of semaglutide will bind to albumin, reducing the free peptide concentration available for GLP-1R engagement. For precise receptor pharmacology studies, use serum-free or defined media conditions, or account for albumin binding using rapid equilibrium dialysis (RED assay) data to calculate the free semaglutide fraction at your working concentration. Semaglutide 5mg vials are available from Pinnacle Peptides, verified at ≥99% purity by HPLC and mass spectrometry.
All content is intended for in vitro laboratory research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any condition.
